Get the Stockscreener App
21.27
1.24%
0.26
Fulgent Genetics Inc stock is traded at $21.27, with a volume of 40,399.
It is up +1.24% in the last 24 hours and down -0.05% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
See More
Previous Close:
$21.01
Open:
$21.05
24h Volume:
40,399
Relative Volume:
0.13
Market Cap:
$585.25M
Revenue:
$320.35M
Net Income/Loss:
$-75.01M
P/E Ratio:
-8.8799
EPS:
-2.3953
Net Cash Flow:
$-113.17M
1W Performance:
+2.16%
1M Performance:
-0.05%
6M Performance:
+31.54%
1Y Performance:
-6.55%
1-Day Range:
$20.86
$21.45
1-Week Range:
$20.65
$21.80
52-Week Range:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
21.27 | 585.25M | 320.35M | -75.01M | -113.17M | -2.3953 |
TMO
Thermo Fisher Scientific Inc
|
693.71 | 256.50B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
231.62 | 162.83B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
402.48 | 58.02B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
176.38 | 49.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.16 | 44.47B | 16.63B | 1.39B | 2.12B | 8.0674 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Upgrade | UBS | Neutral → Buy |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? - Zacks Investment Research
How Fulgent Genetics Inc. (FLGT) Affects Rotational Strategy Timing - Stock Traders Daily
Bank of New York Mellon Corp Purchases New Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Public Employees Retirement System of Ohio Makes New Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
Hsieh Ming Surrenders 4,392 Shares of Fulgent Genetics at $19.59 Each - Kalkine Media
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics CFO Kim Paul Surrenders 2,087 Shares at $19.59 Each - Kalkine Media
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock - Investing.com Australia
FLGT Q2 2026 Earnings: Wider-Than-Expected Loss of -$0.58 Pressures SharesEarnings Revision Downgrade - vinanet.vn
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock - Investing.com UK
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock - Investing.com Nigeria
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock - Investing.com India
Fulgent Genetics (NASDAQ:FLGT) COO Sells 2,127 Shares - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Insider Sells $32,891.18 in Stock - MarketBeat
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock - Investing.com
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock By Investing.com - Investing.com UK
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock By Investing.com - Investing.com Canada
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) officer to sell 45,304 vested shares for taxes - Stock Titan
Fulgent Genetics (FLGT) officer plans stock sale to cover taxes - Stock Titan
BlackRock Inc. Makes New $46.92 Million Investment in Fulgent Genetics, Inc. $FLGT - marketbeat.com
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Purchases New Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded at Wall Street Zen - MarketBeat
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com Nigeria
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock - Investing.com India
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com Australia
Jian Xie Sells 1,193 Shares of Fulgent Genetics (NASDAQ:FLGT) Stock - MarketBeat
Fulgent Genetics COO Xie Jian disposes of $23,747 in company stock - Investing.com
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com Canada
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com UK
Fulgent Genetics (NASDAQ: FLGT) holder plans tax-driven share sale - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) officer plans tax-withholding share sale - Stock Titan
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock - Investing.com
Fulgent Genetics COO Xie Jian disposes of $23,747 in company stock - Investing.com UK
FLGT | Fulgent Genetics, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Fulgent (FLGT) Technicals: Slides 0.10% to $19.90 at the Close; the Near-Term Reference Band Stretches From $18.90 to $20.89 under the Current SnapshotPrice Action Signals - vinanet.vn
Renaissance Technologies LLC Decreases Stock Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Share Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations - tradersunion.com
Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP - MarketBeat
Discipline and Rules-Based Execution in FLGT Response - Stock Traders Daily
Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell - MarketBeat
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - AOL.com
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - The Globe and Mail
Fulgent Genetics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking Alpha
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fulgent Genetics Inc Stock (FLGT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Xie Jian | Officer |
Sep 02 '26 |
Proposed Sale |
19.66 |
2,127 |
41,809 |
0 |
| Xie Jian | President and COO |
Sep 02 '26 |
Sale |
19.66 |
2,127 |
41,809 |
359,924 |
| Gao Hanlin | Officer |
Sep 02 '26 |
Proposed Sale |
19.66 |
1,673 |
32,885 |
0 |
| Xie Jian | President and COO |
Aug 27 '26 |
Sale |
19.91 |
1,193 |
23,747 |
362,051 |
| Gao Hanlin | Chief Scientific Officer |
Aug 27 '26 |
Sale |
19.91 |
939 |
18,691 |
987,790 |
| Gao Hanlin | Officer |
Aug 27 '26 |
Proposed Sale |
19.91 |
939 |
18,691 |
0 |
| Xie Jian | Officer |
Aug 27 '26 |
Proposed Sale |
19.91 |
1,193 |
23,747 |
0 |
| Xie Jian | President and COO |
Jun 02 '26 |
Sale |
17.89 |
2,146 |
38,382 |
367,605 |
| Gao Hanlin | Chief Scientific Officer |
Jun 02 '26 |
Sale |
17.89 |
1,688 |
30,191 |
990,374 |
| Xie Jian | Officer |
Jun 02 '26 |
Proposed Sale |
17.89 |
2,146 |
38,382 |
0 |
5.90%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):